CCMI
EW icon

Creative Capital Management Investments’s Edwards Lifesciences EW Stock Holding History

Creative Capital Management Investments’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.71K Buy
+41
New +$3.44K ﹤0.01% 532

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Creative Capital Management Investments's EW Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in Edwards Lifesciences (EW) in Q2 2026: 41 shares worth $3.71K. The stake represents ﹤0.01% of the portfolio and ranks #532 among its holdings.

372 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Creative Capital Management Investments held 41 shares of Edwards Lifesciences worth $3.71K as of Q2 2026.
  • Edwards Lifesciences was a new Creative Capital Management Investments position in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #532 holding.
  • 372 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.